![]() |
VICTORIA, Seychelles, April 28, 2025 /PRNewswire/ — SquaredFinancial, a global leader in fintech and trading solutions, is proud to announce a major update to its trading conditions: the maximum leverage offered on major Forex pairs, gold, and silver has been doubled, reaching up to 1:2000.
This significant increase empowers traders to open larger positions with a smaller capital, offering more flexibility and the potential to seize greater opportunities, especially in today’s volatile markets.
Always responsive to the evolving needs of today’s traders, SquaredFinancial continues to enhance its offering to ensure clients have the tools and support they need to trade on their own terms, keeping them aware of the risks that trading entails. Whether capitalizing on Forex volatility or navigating precious metals, traders can now do so with amplified power.
About SquaredFinancial
SquaredFinancial is a well-capitalized FinTech firm founded in 2005. It aims to become a one-stop shop that meets investors’ financial needs. With around two decades of experience in financial technology and trading, it offers global solutions to traders of different generations and backgrounds, who are looking for an intuitive and sophisticated investment gateway. It is led by market experts and leadership veterans who share a passion for trading and a vision to reshape the industry landscape. As a regulated firm, it provides investors with an online platform backed by cutting-edge technology that offers the opportunity to trade a wide range of instruments from different asset classes. SquaredFinancial has launched its proprietary mobile trading app and its innovative fixed-time deposit account.
ข่าวที่เกี่ยวข้อง
- Xinhua Silk Road: Jing’an District promotes investment opportunities, global business cooperation at 2026 CIIE
- Binance Blockchain Week Bangkok 2026 Unveils First Wave of Speakers, Spotlighting the Convergence of Traditional Finance and Digital Assets
- Ascletis Submits IND Application to the U.S. FDA for ASC30_39 FDC, a Potentially First-in-Class Oral Small Molecule Fixed-Dose Combination of GLP-1R Agonist and Selective Amylin Receptor Agonist, for the Treatment of Obesity
- Ali Y. Koç: ‘The Energy Transition Has Become the Cornerstone of Competitiveness in Industry’


